908 Devices (MASS) Net Income towards Common Stockholders (2020 - 2026)
908 Devices' (MASS) quarterly Net Income towards Common Stockholders came in at -$14.9 million in Q1 2026, down 127.84% year-on-year from $53.4 million in Q1 2025, and down 7192.65% on a QoQ basis from -$204000.0 in Q4 2025.
908 Devices (MASS) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$14.9 million in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 127.84% year-over-year to -$14.9 million in Q1 2026; TTM through Mar 2026 was -$15.6 million, a 139.47% decrease from a year earlier, with the FY2025 full-year figure at $52.8 million, up 376.75% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$14.9 million, down from -$204000.0 in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for MASS reached as high as $53.4 million in Q1 2025 and fell as low as -$14.9 million in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged -$3.1 million across 5 years, with a median of -$6.3 million in 2022.
- Across the five-year window, Net Income towards Common Stockholders jumped 1164.12% in 2025 and tumbled 127.84% in 2026, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$9.8 million in 2022, then advanced by 24.12% to -$7.4 million in 2023, then surged by 53.94% to -$3.4 million in 2024, then soared by 94.04% to -$204000.0 in 2025, then plunged by 7192.65% to -$14.9 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$14.9 million in Q1 2026, -$204000.0 in Q4 2025, and -$72000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 176.78 Mn |
| 10 | 908 Devices | 260.31 Mn | 148.57 Mn | 6.88 Mn | -14.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.88 Mn |
| Dec 31, 2025 | -204,000.00 |
| Sep 30, 2025 | -72,000.00 |
| Jun 30, 2025 | -398,000.00 |
| Mar 31, 2025 | 53.44 Mn |
| Dec 31, 2024 | -3.42 Mn |
| Sep 30, 2024 | -5.65 Mn |
| Jun 30, 2024 | -4.98 Mn |
| Mar 31, 2024 | -5.02 Mn |
| Dec 31, 2023 | -7.43 Mn |
| Sep 30, 2023 | -7.09 Mn |
| Jun 30, 2023 | -9.35 Mn |
| Mar 31, 2023 | -12.53 Mn |
| Dec 31, 2022 | -9.79 Mn |
| Sep 30, 2022 | -6.26 Mn |
| Jun 30, 2022 | -8.10 Mn |
| Mar 31, 2022 | -10.68 Mn |
| Dec 31, 2021 | -7.42 Mn |
| Sep 30, 2021 | -5.19 Mn |
| Jun 30, 2021 | -8.45 Mn |